SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VICL (Vical Labs)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rainforest who wrote (195)5/2/1997 8:33:00 AM
From: John B. Anderson   of 1972
 
Dragonfly: There are other companies working on non-viral approaches to gene therapy, although Vical is probably the foremost. I don't think you should believe that Vical's patent position is forever going to keep away competitiors -- they will challenge and redefine the patent endlessly I suspect.

I know Cell Genesys is experimenting in this area through their acquisition of Somatix Therapy which has a small project in the works....

My comments about the "Roach Motel" attitude of INSTITUTIONS and the reporting of the negative opinions I heard from analysts at Mehta Isaly were simply to convey information, not my views.

I am getting interested in VICL at these prices. Before I thought the price was clearly ridiculous. Can anyone summarize the arguments for buying the stock for long term reward? Thanks!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext